Genomics research is the key to personalised medicine. In genomics, researchers study what it is about an individual’s genetic interactions and environment that can change the way their unique combination of genes influences a particular disease, and their response to a type and dose of medicine or other therapy.
Dr Shalin Naik is one of the researchers who works with the DROP-seq.
“Traditionally, researchers have been restricted to studying biological systems by looking at aggregated samples of cells,” he said. The DROP-seq will change that by allowing researchers to look at single cells to learn how they influence the way we respond to therapies.